| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/13/2002 | EP1178799A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 02/13/2002 | EP1178797A1 Inhibitors of impdh enzyme |
| 02/13/2002 | EP1178795A1 Dfmo and celecoxib in combination for cancer chemoprevention and therapy |
| 02/13/2002 | EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response |
| 02/13/2002 | EP0737199B1 Method for preparing concentrated biologically active silicon compounds |
| 02/13/2002 | EP0630257B1 Thymus-derived, immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/13/2002 | CN1335853A Alpha v beta b integrin inhibitors |
| 02/13/2002 | CN1335852A Novel depsipeptide compound |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them |
| 02/13/2002 | CN1335839A Bis-sulfonamides |
| 02/13/2002 | CN1335838A Pyrimidine compounds |
| 02/13/2002 | CN1335836A Tricyclic pyrazole derivatives |
| 02/13/2002 | CN1335779A The preparation and use of radium-223 to target calcified tissues for pain palliation bone cancer therapy, and bone surface conditioning |
| 02/13/2002 | CN1335771A N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 02/13/2002 | CN1335770A Spisulosine compounds having antitumour activity |
| 02/13/2002 | CN1335749A Method and compositions for treatment of cell proliferative disorders |
| 02/13/2002 | CN1335398A Recombinant adenovirus vector capable of being duplicated and spread specifcally inside tumor cell |
| 02/13/2002 | CN1335161A Deer bone powder capsule |
| 02/13/2002 | CN1335159A Jinxitang Decoction for treating tumor |
| 02/13/2002 | CN1335145A External-use plaster for softening dry feces and dissipating mass |
| 02/13/2002 | CN1335140A Medicine bolus for dredging meridian passage, nourishing blood and removing toxic material |
| 02/13/2002 | CN1335134A Composition and method for preventing and treating breast cancer |
| 02/13/2002 | CN1335133A Composition and method for preventing and curing breast cancer |
| 02/13/2002 | CN1335105A Anticancer health tea and its production process |
| 02/13/2002 | CN1079097C Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 02/13/2002 | CN1079096C Arylsulfonylimidazolone derivatives as antitumor agent |
| 02/12/2002 | US6346633 Anti-tumuor agents |
| 02/12/2002 | US6346626 Drugs for treatment of skin disorders such as acne, seborrhea, androgenic alopecia and hirsutism, or in the topical treatment of squamous cell carcinoma |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346606 A protein; diagnosis and therapy for tumor diseases, central nervous system diseases, glioblastomas, and breast cancer |
| 02/12/2002 | US6346602 Peptide mimics of the cytokine receptor common γ chain and methods and compositions for making and using the same |
| 02/12/2002 | US6346550 Hydroxylation activated prodrugs |
| 02/12/2002 | US6346546 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
| 02/12/2002 | US6346543 Administering baccatin derivative as anticarcinogenic agent |
| 02/12/2002 | US6346541 Antitumor and anticarcinogenic agents for breast, lung, and skin cancer |
| 02/12/2002 | US6346539 Treatment of skin conditions |
| 02/12/2002 | US6346520 Antitumor and anticarcinogenic agents; psoriasis |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
| 02/12/2002 | US6346251 Antiproliferation agents for skin disorders |
| 02/12/2002 | US6346248 Methods of treating autoimmune diseases with a CD86-specific immunotoxin |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | US6346233 Composition for treating cancer via liposomal aerosol formulation containing taxol |
| 02/12/2002 | CA2259152C Adenovirus e4 proteins for inducing cell death |
| 02/12/2002 | CA2221190C Novel substituted taxanes and pharmaceutical compositions containing them |
| 02/12/2002 | CA2174105C Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/12/2002 | CA2125500C Composition of antineoplastic agents incorporated in micelles |
| 02/07/2002 | WO2002010766A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors |
| 02/07/2002 | WO2002010764A2 SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY |
| 02/07/2002 | WO2002010743A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | WO2002010408A1 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same |
| 02/07/2002 | WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | WO2002010405A2 A human disintegrin protein |
| 02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 02/07/2002 | WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | WO2002010393A2 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010382A2 Trp8, trp9 and trp10, markers for cancer |
| 02/07/2002 | WO2002010379A2 Modified cea and uses thereof |
| 02/07/2002 | WO2002010378A2 Antisense modulation of ptp1b expression |
| 02/07/2002 | WO2002010371A1 Novel physiologically active peptide and use thereof |
| 02/07/2002 | WO2002010369A1 Tumor antigen |
| 02/07/2002 | WO2002010368A1 Tumor-specific promoters |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010217A2 Endothelial cell expression patterns |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010215A1 Somatostatin analogs for the treatment of cancer |
| 02/07/2002 | WO2002010211A1 A new polypeptide- human zinc finger protein 12.98 and the polynucloetide encoding it |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010194A1 Substance p analogs for the treatment of cancer |
| 02/07/2002 | WO2002010193A1 Lipid-peptide conjugates for treatment of cancer |
| 02/07/2002 | WO2002010192A2 Somatostatin analogues |
| 02/07/2002 | WO2002010191A2 Immunomodulatory compounds |
| 02/07/2002 | WO2002010173A1 Dihydroporphyrin derivatives and their uses |
| 02/07/2002 | WO2002010168A1 Novel guanidino derivatives as inhibitors of cell adhesion |
| 02/07/2002 | WO2002010166A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 02/07/2002 | WO2002010165A1 Use of polycyclic aromatic compounds for making medicines capable of inhibiting telomerase |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | WO2002010161A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 02/07/2002 | WO2002010152A2 Novel indole derivatives and their use as medicaments |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010143A1 Non-steroidal inflammation inhibitors |
| 02/07/2002 | WO2002010142A1 Cyclic polyamine compounds for cancer therapy |
| 02/07/2002 | WO2002010141A1 Imidazole derivatives |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002010120A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 02/07/2002 | WO2002010119A1 Preparation of sterile crystals of 5-aminolevulinic acid utilized for medical diagnostic and therapeutic purposes, and a device for facilitating this diagnostic process |
| 02/07/2002 | WO2002009768A2 Therapeutic polyesters and polyamides |
| 02/07/2002 | WO2002009755A2 Apo-2l receptor agonist and cpt-11 synergism |
| 02/07/2002 | WO2002009754A1 Novel remedies for cancer |
| 02/07/2002 | WO2002009747A1 Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
| 02/07/2002 | WO2002009744A2 Modified sialic acid vaccines |
| 02/07/2002 | WO2002009743A1 Method for treating a neoplasm |
| 02/07/2002 | WO2002009716A2 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | WO2002009715A2 Use of an arylaldehyde 5-oxo-1, 2, 4-triazine hydrazide for the treatment of cancer |